Tag archive for ‘XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB); TASE:XTL)’
Globes On Sunday, September 15th, 2013

Zmiha acquires Proteologics

– Proteologics has NIS 25 million ($6.9 millio) in cash and frozen activity, which was an incentive for the deal. –   – / By Globes’ correspondent and Gali Weinreb Zmiha Investment More...

Globes On Sunday, July 14th, 2013

XTL Bio returns to Nasdaq

– XTL’s lead product is a treatment of multiple myeloma, and it is readying a clinical trial for the product. – / By Gali Weinreb /  XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB); TASE:XTL) More...

Wordpress site Developed by Fixing WordPress Problems